Hu FJ - Search Results

1

Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.

Wang YP, Zhou LS, Zhao YZ, Wang SW, Chen LL, Liu LX, Ling ZQ, Hu FJ, Sun YP, Zhang JY, Yang C, Yang Y, Xiong Y, Guan KL, Ye D. Wang YP, et al. Among authors: hu fj. EMBO J. 2014 Jun 17;33(12):1304-20. doi: 10.1002/embj.201387224. Epub 2014 Apr 25. EMBO J. 2014. PMID: 24769394 Free PMC article.

2

Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.

Mao WM, Li P, Zheng QQ, Wang CC, Ge MH, Hu FJ, Fang XH, Dong ZM, Ling ZQ. Mao WM, et al. Among authors: hu fj. Arch Med Res. 2011 Apr;42(3):182-8. doi: 10.1016/j.arcmed.2011.04.002. Arch Med Res. 2011. PMID: 21722812

3

Unfavorable clinical implications of circulating CD44+ lymphocytes in patients with nasopharyngeal carcinoma undergoing radiochemotherapy.

Hu FJ, Ge MH, Li P, Wang CC, Ling YT, Mao WM, Ling ZQ. Hu FJ, et al. Clin Chim Acta. 2012 Jan 18;413(1-2):213-8. doi: 10.1016/j.cca.2011.09.026. Epub 2011 Sep 29. Clin Chim Acta. 2012. PMID: 21983162

4

Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.

Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM. Ling ZQ, et al. Among authors: hu fj. Dig Dis Sci. 2011 Oct;56(10):2992-3004. doi: 10.1007/s10620-011-1774-z. Epub 2011 Jun 15. Dig Dis Sci. 2011. PMID: 21674174

5

Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.

Ling ZQ, Li P, Ge MH, Zhao X, Hu FJ, Fang XH, Dong ZM, Mao WM. Ling ZQ, et al. Among authors: hu fj. Int J Mol Med. 2011 May;27(5):625-35. doi: 10.3892/ijmm.2011.640. Epub 2011 Mar 3. Int J Mol Med. 2011. PMID: 21373750

6

Clinical and prognostic analysis in 32 pediatric nasopharyngeal carcinoma.

Chen J, Hu F. Chen J, et al. J Cancer Res Ther. 2015 Oct;11 Suppl 2:C226-9. doi: 10.4103/0973-1482.168191. J Cancer Res Ther. 2015. PMID: 26506882 Free article.

7

Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma.

Chen J, Liu T, Sun Q, Hu F. Chen J, et al. Medicine (Baltimore). 2018 Dec;97(49):e13483. doi: 10.1097/MD.0000000000013483. Medicine (Baltimore). 2018. PMID: 30544441 Free PMC article.

8

Arterial interventional chemotherapy and IMRT with concurrent chemotherapy for nasopharyngeal carcinoma with intracranial involvement.

Fen X, Qin W, Bao W, Jiang F, Li B, Hu F, Chen X. Fen X, et al. Oncol Lett. 2013 Aug;6(2):427-431. doi: 10.3892/ol.2013.1407. Epub 2013 Jun 17. Oncol Lett. 2013. PMID: 24137340 Free PMC article.

9

miR-195 is a key regulator of Raf1 in thyroid cancer.

Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F. Wang F, et al. Onco Targets Ther. 2015 Oct 20;8:3021-8. doi: 10.2147/OTT.S90710. eCollection 2015. Onco Targets Ther. 2015. PMID: 26527888 Free PMC article.

10

Downregulation of miR‑429 and inhibition of cell migration and invasion in nasopharyngeal carcinoma.

Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F. Wang F, et al. Mol Med Rep. 2016 Apr;13(4):3236-42. doi: 10.3892/mmr.2016.4940. Epub 2016 Feb 23. Mol Med Rep. 2016. PMID: 26936585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters